Recent advances in GNAS epigenetic research of pseudohypoparathyroidism

Current Molecular Medicine

Volumn 12, Issue 5, 2012, Pages 566-573

  Izzi, B ^a   van Geet, C ^a,b   Freson, K ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

DNA methylation; GNAS cluster; Imprinting; Pseudohypoparathyroidism

Indexed keywords

GENOMIC DNA;

ALBRIGHT SYNDROME; BEHAVIOR DISORDER; DISEASE CLASSIFICATION; DNA METHYLATION; EPIGENETICS; EXTRACHROMOSOMAL INHERITANCE; GENE CLUSTER; GENE LOCUS; GENE MUTATION; GENETIC SCREENING; GENETIC TRANSCRIPTION; GENOME IMPRINTING; GNAS GENE; HORMONE RESISTANCE; HUMAN; HYPERPHOSPHATEMIA; HYPOCALCEMIA; MENTAL DEFICIENCY; POLYMERASE CHAIN REACTION; PSEUDOHYPOPARATHYROIDISM; REVIEW; SHORT STATURE; SOUTHERN BLOTTING;

EID: 84860992917     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/156652412800619969     Document Type: Review

References (78)

1. Kozasa T, Itoh H, Tsukamoto T, Kaziro Y. Isolation and characterization of the human Gs alpha gene. Proc Natl Acad Sci USA 1988; 85(7): 2081-2085.
2. Bray P, Carter A, Simons C, et al. Human cDNA clones for four species of G alpha s signal transduction protein. Proc Natl Acad Sci USA 1986; 83(23): 8893-8897.
3. Davies SJ, Hughes HE. Imprinting in Albright's hereditary osteodystrophy. J Med Genet 1993; 30(2): 101-103.
4. Campbell R, Gosden CM, Bonthron DT. Parental origin of transcription from the human GNAS1 gene. J Med Genet 1994; 31(8): 607-614.
5. Yu S, Yu D, Lee E, et al. Variable and tissue-specific hormone resistance in heterotrimeric Gs protein alphasubunit (Gsalpha) knockout mice is due to tissue-specific imprinting of the gsalpha gene. Proc Natl Acad Sci USA 1998; 95(15): 8715-8720.
6. Hayward BE, Barlier A, Korbonits M, et al. Imprinting of the G(s)alpha gene GNAS1 in the pathogenesis of acromegaly. J Clin invest 2001; 107(6): R31-R36.
7. Weinstein LS. The stimulatory G protein alpha-subunit gene: mutations and imprinting lead to complex phenotypes. J Clin Endocrinol Metab 2001; 86(10): 4622-4626.
8. Germain-Lee EL, Ding CL, Deng Z, et al. Paternal imprinting of Galpha(s) in the human thyroid as the basis of TSH resistance in pseudohypoparathyroidism type 1a. Biochem Biophys Res Commun 2002; 296(1): 67-72.
9. Mantovani G, Ballare E, Giammona E, Beck-Peccoz P, Spada A. The gsalpha gene: predominant maternal origin of transcription in human thyroid gland and gonads. J Clin Endocrinol Metab 2002; 87(10): 4736-4740.
10. Liu J, Erlichman B, Weinstein LS. The stimulatory G protein alpha-subunit Gs alpha is imprinted in human thyroid glands: implications for thyroid function in pseudohypoparathyroidism types 1A and 1B. J Clin Endocrinol Metab 2003; 88(9): 4336-4341.
11. Ishikawa Y, Bianchi C, Nadal-Ginard B, Homcy CJ. Alternative promoter and 5' exon generate a novel Gs alpha mRNA. J Biol Chem 1990; 265(15): 8458-8462.
12. Liu J, Litman D, Rosenberg MJ, Yu S, Biesecker LG, Weinstein LS. A GNAS1 imprinting defect in pseudohypoparathyroidism type IB. J Clin invest 2000; 106(9): 1167-11674.
13. Liu J, Yu S, Litman D, Chen W, Weinstein LS. Identification of a methylation imprint mark within the mouse Gnas locus. Mol Cell Biol 2000; 20(16): 5808-5817.
14. Kehlenbach RH, Matthey J, Huttner WB. XL alpha s is a new type of G protein. Nature 1994; 372(6508): 804-809.
15. Hayward BE, Kamiya M, Strain L, et al. The human GNAS1 gene is imprinted and encodes distinct paternally and biallelically expressed G proteins. Proc Natl Acad Sci USA 1998; 95(17): 10038-10043.
16. Kelsey G, Bodle D, Miller HJ, et al. Identification of imprinted loci by methylation-sensitive representational difference analysis: application to mouse distal chromosome 2. Genomics 1999; 62(2): 129-138.
17. Peters J, Wroe SF, Wells CA, et al. A cluster of oppositely imprinted transcripts at the Gnas locus in the distal imprinting region of mouse chromosome 2. Proc Natl Acad Sci USA 1999; 96(7): 3830-3835.
18. Li T, Vu TH, Zeng ZL, et al. Tissue-specific expression of antisense and sense transcripts at the imprinted Gnas locus. Genomics 2000; 69(3): 295-304.
19. Hayward BE, Moran V, Strain L, Bonthron DT. Bidirectional imprinting of a single gene: GNAS1 encodes maternally, paternally, and biallelically derived proteins. Proc Natl Acad Sci USA 1998; 95(26): 15475-1580.
20. Ischia R, Lovisetti-Scamihorn P, Hogue-Angeletti R, Wolkersdorfer M, Winkler H, Fischer-Colbrie R. Molecular cloning and characterization of NESP55, a novel chromogranin-like precursor of a peptide with 5-HT1B receptor antagonist activity. J Biol Chem 1997; 272(17): 11657-11662.
21. Hayward BE, Bonthron DT. An imprinted antisense transcript at the human GNAS1 locus. Hum Mol Genet 2000; 9(5): 835-841.
22. Wroe SF, Kelsey G, Skinner JA, et al. An imprinted transcript, antisense to Nesp, adds complexity to the cluster of imprinted genes at the mouse Gnas locus. Proc Natl Acad Sci USA 2000; 97(7): 3342-3346.
23. Williamson CM, Skinner JA, Kelsey G, Peters J. Alternative non-coding splice variants of Nespas, an imprinted gene antisense to Nesp in the Gnas imprinting cluster. Mammalian genome 2002; 13(2): 74-79.
24. Coombes C, Arnaud P, Gordon E, et al. Epigenetic properties and identification of an imprint mark in the Nesp-Gnasxl domain of the mouse Gnas imprinted locus. Mol Cell Biol 2003; 23(16): 5475-5488.
25. Weinstein LS, Liu J, Sakamoto A, Xie T, Chen M. Minireview: GNAS: normal and abnormal functions. Endocrinology 2004; 145(12): 5459-5464.
26. Jan de Beur SL, M.A. Pseudohypoparathyroidism: clinical, biochemical, and molecular features. Academic Press, New York 2001.
27. Bastepe M, Juppner H. Pseudohypoparathyroidism, Albright's Hereditary Osteodistriphy, and Progressive Osseous Heteroplasia: disorders caused by inactivating GNAS mutations. 6th ed: W.B. Saunders Company, Philadelphia 2010.
28. Albright F, Burnett CH, Smith PH, Parson W. Pseudohypoparathyroidism- an example of Seabright syndrome. Endocrinology 1942; 30: 922-932.
29. Mantovani G, Maghnie M, Weber G, et al. Growth hormonereleasing hormone resistance in pseudohypoparathyroidism type ia: new evidence for imprinting of the Gs alpha gene. J Clin Endocrinol Metab 2003; 88(9): 4070-4074.
30. Germain-Lee EL, Groman J, Crane JL, Jan de Beur SM, Levine MA. Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance. J Clin Endocrinol Metab 2003; 88(9): 4059-4069.
31. Levine MA, Downs RW, Jr., Moses AM, et al. Resistance to multiple hormones in patients with pseudohypoparathyroidism.Association with deficient activity of guanine nucleotide regulatory protein. Am J Med 1983; 74(4): 545-556.
32. Wolfsdorf JI, Rosenfield RL, Fang VS, Kobayashi R, Razdan AK, Kim MH. Partial gonadotrophin-resistance in pseudohypoparathyroidism. Acta Endocrinol (Copenh) 1978; 88(2): 321-328.
33. Mantovani G, Bondioni S, Linglart A, et al. Genetic analysis and evaluation of resistance to thyrotropin and growth hormone-releasing hormone in pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab 2007; 92(9): 3738-3742.
34. Long DN, McGuire S, Levine MA, Weinstein LS, Germain- Lee EL. Body mass index differences in pseudohypoparathyroidism type 1a versus pseudopseudohypoparathyroidism may implicate paternal imprinting of Galpha(s) in the development of human obesity. J Clin Endocrinol Metab 2007; 92(3): 1073-1079.
35. Wilson LC, Oude Luttikhuis ME, Clayton PT, Fraser WD, Trembath RC. Parental origin of Gs alpha gene mutations in Albright's hereditary osteodystrophy. J Med Genet 1994; 31(11): 835-839.
36. Bastepe M, Juppner H. GNAS locus and pseudohypoparathyroidism. Horm Res 2005; 63(2): 65-74.
37. Weinstein LS, Yu S, Warner DR, Liu J. Endocrine manifestations of stimulatory G protein alpha-subunitmutations and the role of genomic imprinting. Endocr Rev 2001; 22(5): 675-705.
38. Bastepe M, Pincus JE, Sugimoto T, et al. Positional dissociation between the genetic mutation responsible for pseudohypoparathyroidism type Ib and the associated methylation defect at exon A/B: evidence for a long-range regulatory element within the imprinted GNAS1 locus. Hum Mol Genet 2001; 10(12): 1231-1241.
39. Liu J, Nealon JG, Weinstein LS. Distinct patterns of abnormal GNAS imprinting in familial and sporadic pseudohypoparathyroidism type IB. Hum Mol Genet 2005; 14(1): 95-102.
40. Jan de Beur S, Ding C, Germain-Lee E, Cho J, Maret A, Levine MA. Discordance between genetic and epigenetic defects in pseudohypoparathyroidism type 1b revealed by inconsistent loss of maternal imprinting at GNAS1. Am J Hum Genet 2003; 73(2): 314-322.
41. Bastepe M, Frohlich LF, Hendy GN, et al. Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS. J Clin Invest 2003; 112(8): 1255-1263.
42. Linglart A, Gensure RC, Olney RC, Juppner H, Bastepe M. A novel STX16 deletion in autosomal dominant pseudohypoparathyroidism type Ib redefines the boundaries of a cis-acting imprinting control element of GNAS. Am J Hum Genet 2005; 76(5): 804-814.
43. Liu J, Chen M, Deng C, et al. Identification of the control region for tissue-specific imprinting of the stimulatory G protein alpha-subunit. Proc Natl Acad Sci USA 2005; 102(15): 5513-5518.
44. Linglart A, Bastepe M, Juppner H. Similar clinical and laboratory findings in patients with symptomatic autosomal dominant and sporadic pseudohypoparathyroidism type Ib despite different epigenetic changes at the GNAS locus. Clin Endocrinol (Oxf) 2007; 67(6): 822-831.
45. Maupetit-Mehouas S, Mariot V, Reynes C, et al. Quantification of the methylation at the GNAS locus identifies subtypes of sporadic pseudohypoparathyroidism type Ib. J Med Genet 2011; 48(1): 55-63.
46. Izzi B, Decallonne B, Devriendt K, et al. A new approach to imprinting mutation detection in GNAS by Sequenom EpiTYPER system. Clin Chim Acta 2010; 411(23/24): 2033-2039.
47. Cavaco BM, Tomaz RA, Fonseca F, Mascarenhas MR, Leite V, Sobrinho LG. Clinical and genetic characterization of Portuguese patients with pseudohypoparathyroidism type Ib. Endocrine 2010; 37(3): 408-414.
48. Bastepe M, Lane AH, Juppner H. Paternal uniparental isodisomy of chromosome 20q--and the resulting changes in GNAS1 methylation--as a plausible cause of pseudohypoparathyroidism. Am J Hum Genet 2001; 68(5): 1283-1289.
49. Fernandez-Rebollo E, Lecumberri B, Garin I, et al. New mechanisms involved in paternal 20q disomy associated with pseudohypoparathyroidism. Eur J Endocrinol 2010; 163(6): 953-962.
50. Bastepe M, Altug-Teber O, Agarwal C, Oberfield SE, Bonin M, Juppner H. Paternal uniparental isodisomy of the entire chromosome 20 as a molecular cause of pseudohypoparathyroidism type Ib (PHP-Ib). Bone 2011; 48(3): 659-662.
51. Fernandez-Rebollo E, Perez de Nanclares G, Lecumberri B, et al. Exclusion of the GNAS locus in PHP-Ib patients with broad GNAS methylation changes: evidence for an autosomal recessive form of PHP-Ib? J Bone Miner Res 2011; 26.
52. Breslau NA, Weinstock RS. Regulation of 1,25 (OH)2D synthesis in hypoparathyroidism and pseudohypoparathyroidism. Am J Physiol 1988; 255(5 Pt 1):E730-E736.
53. Drezner MK, Neelon FA, Haussler M, McPherson HT, Lebovitz HE. 1,25-Dihydroxycholecalciferol deficiency: the probable cause of hypocalcemia and metabolic bone disease in pseudohypoparathyroidism. J Clin Endocrinol Metab 1976; 42(4): 621-628.
54. de Nanclares GP, Fernandez-Rebollo E, Santin I, et al. Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy. J Clin Endocrinol Metab 2007; 92(6): 2370-2373.
55. Mariot V, Maupetit-Mehouas S, Sinding C, Kottler ML, Linglart A. A maternal epimutation of GNAS leads to Albright osteodystrophy and parathyroid hormone resistance. J Clin Endocrinol Metab 2008; 93(3): 661-665.
56. Mantovani G, de Sanctis L, Barbieri AM, et al. Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients. J Clin Endocrinol Metab 2010; 95(2): 651-658.
57. Lecumberri B, Fernandez-Rebollo E, Sentchordi L, et al. Coexistence of two different pseudohypoparathyroidism subtypes (Ia and Ib) in the same kindred with independent Gs{alpha} coding mutations and GNAS imprinting defects. J Med Genet 2010; 47(4): 276-280.
58. Lania A, Mantovani G, Spada A. G protein mutations in endocrine diseases. Eur J Endocrinol 2001; 145(5): 543-559.
59. Ahrens W, Hiort O, Staedt P, Kirschner T, Marschke C, Kruse K. Analysis of the GNAS1 gene in Albright's hereditary osteodystrophy. J Clin Endocrinol Metab 2001; 86(10):4630-4634.
60. Freson K, Izzi B, Labarque V, et al. GNAS defects identified by stimulatory G protein alpha-subunit signalling studies in platelets. J Clin Endocrinol Metab 2008; 93(12):4851-4859.
61. Freson K, Thys C, Wittevrongel C, et al. Pseudohypoparathyroidism type Ib with disturbed imprinting in the GNAS1 cluster and Gsalpha deficiency in platelets. Hum Mol Genet 2002; 11(22): 2741-2750.
62. Weinstein LS. Albright Hereditary Osetodystrophy, pseudohypoparathyroidism and Gs deficiency. In: Spiegel A. M. G proteins, receptors and disease.: Clifton, NJ: Human Press 1998.
63. Thiele S, de Sanctis L, Werner R, et al. Functional characterization of GNAS mutations found in patients with pseudohypoparathyroidism type Ic defines a new subgroup of pseudohypoparathyroidism affecting selectively Gsalphareceptor interaction. Hum Mutat 2011; 32(6): 653-660.
64. Marguet C, Mallet E, Basuyau JP, Martin D, Leroy M, Brunelle P. Clinical and biological heterogeneity in pseudohypoparathyroidism syndrome. Results of a multicenter study. Horm Res 1997; 48(3): 120-130.
65. Zazo C, Thiele S, Martin C, et al. Gsalpha activity is reduced in erythrocyte membranes of patients with pseudohypoparathyrodism due to epigenetic alterations at the GNAS locus. J Bone Miner Res 2011; 23.
66. Ammerpohl O, Martin-Subero JI, Richter J, Vater I, Siebert R. Hunting for the 5th base: Techniques for analyzing DNA methylation. Biochim Biophys Acta 2009; 1790(9): 847-862.
67. Demura M, Takeda Y, Yoneda T, Furukawa K, Tachi A, Mabuchi H. Completely skewed X-inactivation in a mentally retarded young female with pseudohypoparathyroidism type IB and juvenile renin-dependent hypertension. J Clin Endocrinol Metab 2003; 88(7): 3043-3049.
68. Bliek J, Verde G, Callaway J, et al. Hypomethylation at multiple maternally methylated imprinted regions including PLAGL1 and GNAS loci in Beckwith-Wiedemann syndrome. Eur J Hum Genet 2009; 17(5): 611-619.
69. Poole RL, Baple E, Crolla JA, Temple IK, Mackay DJ. Investigation of 90 patients referred for molecular cytogenetic analysis using aCGH uncovers previously unsuspected anomalies of imprinting. Am J Med Genet A 2010; 152A(8): 1990-1993.
70. Baple EL, Poole RL, Mansour S, et al. An atypical case of hypomethylation at multiple imprinted loci. Eur J Hum Genet 2011; 19(3): 360-362.
71. Picard C, Silvy M, Gerard C, et al. Gs alpha overexpression and loss of Gs alpha imprinting in human somatotroph adenomas: association with tumor size and response to pharmacologic treatment. International journal of cancer Journal international du cancer 2007; 121(6): 1245-1252.
72. Weinhaeusel A, Thiele S, Hofner M, Hiort O, Noehammer C. PCR-based analysis of differentially methylated regions of GNAS enables convenient diagnostic testing of pseudohypoparathyroidism type Ib. Clin Chem 2008; 54(9): 1537-1545.
73. Coolen MW, Statham AL, Gardiner-Garden M, Clark SJ. Genomic profiling of CpG methylation and allelic specificity using quantitative high-throughput mass spectrometry: critical evaluation and improvements. Nucleic Acids Res 2007; 35(18): e119.
74. van den Boom D, Ehrich M. Mass spectrometric analysis of cytosine methylation by base-specific cleavage and primer extension methods. Methods Mol Biol 2009 207-227.
75. El-Maarri O, Becker T, Junen J, et al. Gender specific differences in levels of DNA methylation at selected loci from human total blood: a tendency toward higher methylation levels in males. Hum Genet 2007; 122(5): 505-514.
76. Bruce S, Hannula-Jouppi K, Peltonen J, Kere J, Lipsanen-Nyman M. Clinically distinct epigenetic subgroups in Silver Russell syndrome: the degree of H19 hypomethylation associates with phenotype severity and genital and skeletal anomalies. J Clin Endocrinol Metab 2009; 94(2): 579-587.
77. Alsum Z, Abu Safieh L, Nygren AO, Al-Hamed MA, Alkuraya FS. Methylation-specific multiplex-ligation-dependent probe amplification as a rapid molecular diagnostic tool for pseudohypoparathyroidism type 1b. Genet Test Mol Biomarkers 2010; 14(1): 135-139.
78. Ehrich M, Nelson MR, Stanssens P, et al. Quantitative highthroughput analysis of DNA methylation patterns by basespecific cleavage and mass spectrometry. Proc Natl Acad Sci USA 2005; 102(44): 15785-15790.